StockWatch
·

SUN PHARMACEUTICAL INDUSTRIES LTD. Q4 FY25 Results

SUNPHARMAQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue13.0K5.2%
Total Income13.6K4.0%
Expenditure10.0K3.8%
PBT3.3K6.4%
Net Profit2.2K26.1%
OPM25.89%8.86pp
NPM15.87%4.76pp
EPS9.0025.6%
View full financials

Informational and educational content only. Not investment advice.